ClinicalTrialsFinder

Refractory Peripheral T-Cell Lymphoma Clinical Trials in Guanzhou, Guangdong

1 recruitingGuanzhou, Guangdong, China

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

A Study of GFH009 Monotherapy in Patients with Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
Genfleet Therapeutics (Shanghai) Inc.95 enrolled1 locationNCT05934513